Polycab India shares surged after reporting strong Q2 FY26 results, with consolidated net profit up 56% and revenue rising nearly 18% YoY. Analysts remain positive, citing robust growth in wires and cables and FMEG segments, strong exports, and margin expansion. The stock has gained over 40% in six months.
Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma play
Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and